Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise.
作者信息
Lee Brian P, Terrault Norah A
机构信息
Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
Department of Medicine, University of Southern California, Los Angeles, CA, USA.
出版信息
Transl Gastroenterol Hepatol. 2019 Mar 22;4:19. doi: 10.21037/tgh.2019.03.04. eCollection 2019.
Abstract
摘要
相似文献
1
Liver-related mortality in the United States: hepatitis C declines, non-alcoholic fatty liver and alcohol rise.美国与肝脏相关的死亡率：丙型肝炎下降，非酒精性脂肪肝和酒精性肝病上升。
Transl Gastroenterol Hepatol. 2019 Mar 22;4:19. doi: 10.21037/tgh.2019.03.04. eCollection 2019.
2
Viral hepatitis, non-alcoholic fatty liver disease and alcohol as risk factors for hepatocellular carcinoma.病毒性肝炎、非酒精性脂肪性肝病及酒精作为肝细胞癌的危险因素。
Chin Clin Oncol. 2013 Dec;2(4):32. doi: 10.3978/j.issn.2304-3865.2013.09.02.
3
[Alcoholic fatty liver, alcoholic hepatitis and alcoholic cirrhosis. Drinking behavior and incidence of clinical, clinico-chemical and histological findings in 282 patients].[酒精性脂肪肝、酒精性肝炎和酒精性肝硬化。282例患者的饮酒行为及临床、临床化学和组织学检查结果的发生率]
Dtsch Med Wochenschr. 1984 Oct 5;109(40):1516-21. doi: 10.1055/s-2008-1069404.
4
Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.脂肪肝、膳食脂肪酸补充剂及肥胖在酒精性肝病进展中的作用：研讨会介绍与总结
Alcohol. 2004 Aug;34(1):3-8. doi: 10.1016/j.alcohol.2004.06.008.
5
[Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].[非酒精性脂肪性肝炎和脂肪性肝硬化酷似酒精性肝病]
Z Gastroenterol. 1983 Nov;21(11):651-9.
6
Histopathology of Alcohol-Related Liver Diseases.酒精性肝病的组织病理学。
Clin Liver Dis. 2019 Feb;23(1):11-23. doi: 10.1016/j.cld.2018.09.001.
7
Spectrum of Alcoholic Liver Disease.酒精性肝病的谱系
Clin Liver Dis. 2016 Aug;20(3):419-27. doi: 10.1016/j.cld.2016.02.002. Epub 2016 May 31.
8
Epidemiology of alcoholic liver disease.酒精性肝病的流行病学
Baillieres Clin Gastroenterol. 1993 Sep;7(3):555-79. doi: 10.1016/0950-3528(93)90002-a.
9
Pathogenesis, diagnosis, and treatment of alcoholic liver disease.酒精性肝病的发病机制、诊断与治疗
Mayo Clin Proc. 2001 Oct;76(10):1021-9. doi: 10.4065/76.10.1021.
10
Effects of alcohol consumption on histological changes in chronic hepatitis C: a clinicopathological study.饮酒对慢性丙型肝炎组织学变化的影响：一项临床病理研究。
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):106S-111S.
引用本文的文献
1
Role of silymarin as antioxidant in clinical management of chronic liver diseases: a narrative review.水飞蓟素作为抗氧化剂在慢性肝病临床治疗中的作用：叙述性综述。
Ann Med. 2022 Dec;54(1):1548-1560. doi: 10.1080/07853890.2022.2069854.
2
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.估算乙型肝炎和丙型肝炎导致的肝硬化和肝细胞癌的可归因比例。
J Viral Hepat. 2021 Aug;28(8):1177-1189. doi: 10.1111/jvh.13545. Epub 2021 Jun 8.
3
Response differences of HepG2 and Primary Mouse Hepatocytes to morphological changes in electrospun PCL scaffolds.对电纺 PCL 支架形貌变化的 HepG2 和原代鼠肝细胞的反应差异。
Sci Rep. 2021 Feb 4;11(1):3059. doi: 10.1038/s41598-021-81761-z.
本文引用的文献
1
Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.2016 年全球疾病负担研究：1990 年至 2016 年 195 个国家和地区的酒精使用和负担：系统分析。
Lancet. 2018 Sep 22;392(10152):1015-1035. doi: 10.1016/S0140-6736(18)31310-2. Epub 2018 Aug 23.
2
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.美国 1999-2016 年因肝硬化和肝癌导致的死亡率：观察性研究。
BMJ. 2018 Jul 18;362:k2817. doi: 10.1136/bmj.k2817.
3
Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.慢性肝病病因相关年度死亡率的变化趋势：2007 年至 2016 年。
Gastroenterology. 2018 Oct;155(4):1154-1163.e3. doi: 10.1053/j.gastro.2018.07.008. Epub 2018 Sep 1.
4
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.直接抗病毒药物（DAAs）对肝移植的影响：对适应证和结果演变的主要影响。ELITA 研究基于 ELTR 登记处。
J Hepatol. 2018 Oct;69(4):810-817. doi: 10.1016/j.jhep.2018.06.010. Epub 2018 Jun 27.
5
Outcomes of Early Liver Transplantation for Patients With Severe Alcoholic Hepatitis.早期肝移植治疗重症酒精性肝炎患者的结局。
Gastroenterology. 2018 Aug;155(2):422-430.e1. doi: 10.1053/j.gastro.2018.04.009. Epub 2018 Apr 12.
6
The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis.慢性加急性肝衰竭对重症酒精性肝炎病程的预后价值。
J Hepatol. 2018 Aug;69(2):318-324. doi: 10.1016/j.jhep.2018.02.022. Epub 2018 Mar 8.
7
ACG Clinical Guideline: Alcoholic Liver Disease.ACG 临床指南：酒精性肝病。
Am J Gastroenterol. 2018 Feb;113(2):175-194. doi: 10.1038/ajg.2017.469. Epub 2018 Jan 16.
8
OPTN/SRTR 2016 Annual Data Report: Liver.OPTN/SRTR 2016 年度数据报告：肝脏。
Am J Transplant. 2018 Jan;18 Suppl 1:172-253. doi: 10.1111/ajt.14559.
9
Contemporary Policies Regarding Alcohol and Marijuana Use Among Liver Transplant Programs in the United States.美国肝移植项目中当代关于酒精和大麻使用的政策。
Transplantation. 2018 Mar;102(3):433-439. doi: 10.1097/TP.0000000000001969.
10
Prevalence of 12-Month Alcohol Use, High-Risk Drinking, and DSM-IV Alcohol Use Disorder in the United States, 2001-2002 to 2012-2013: Results From the National Epidemiologic Survey on Alcohol and Related Conditions.2001 - 2002年至2012 - 2013年美国12个月酒精使用、高危饮酒及《精神疾病诊断与统计手册》第四版酒精使用障碍的患病率：酒精及相关状况全国流行病学调查结果
JAMA Psychiatry. 2017 Sep 1;74(9):911-923. doi: 10.1001/jamapsychiatry.2017.2161.
Zotero 插件